ArticleClinical Medicine Insights. Oncology2025

Immature Granulocytes and Nivolumab Outcomes in Stage IV Non-Small Cell Lung Cancer: Insights by Tumor Subtype.

Mustafa ErsoyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.